Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Accumulated Depreciation (2020 - 2022)

Immuneering's Accumulated Depreciation history spans 3 years, with the latest figure at $418337.0 for Q4 2022.

  • On a quarterly basis, Accumulated Depreciation rose 140.12% to $418337.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $418337.0, a 140.12% increase, with the full-year FY2022 number at $418337.0, up 140.12% from a year prior.
  • Accumulated Depreciation came in at $418337.0 for Q4 2022, up from $344556.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation was $418337.0 in Q4 2022, with the low at $128752.0 in Q4 2020.
  • Historically, Accumulated Depreciation has averaged $233887.4 across 3 years, with a median of $198071.0 in 2021.
  • Biggest five-year swings in Accumulated Depreciation: skyrocketed 35.31% in 2021 and later surged 140.12% in 2022.
  • Year by year, Accumulated Depreciation stood at $128752.0 in 2020, then soared by 35.31% to $174219.0 in 2021, then skyrocketed by 140.12% to $418337.0 in 2022.
  • Business Quant data shows Accumulated Depreciation for IMRX at $418337.0 in Q4 2022, $344556.0 in Q3 2022, and $276482.0 in Q2 2022.